New Immune-Boosting cancer drug enters first human tests in asia

NCT ID NCT06091930

Summary

This study is testing a new drug called BI 765049, given alone and with another drug called ezabenlimab, for Asian adults with advanced cancers that have stopped responding to standard treatments. The main goals are to find safe doses and see if the treatment can shrink tumors by helping the immune system fight the cancer. It is open to people with specific cancers, like stomach, lung, or liver cancer, whose tumors have a marker called B7-H6.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Japanese Foundation for Cancer Research

    RECRUITING

    Tokyo, Koto-ku, 135-8550, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Kansai Medical University Hospital

    NOT_YET_RECRUITING

    Osaka, Hirakata, 573-1191, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • National Cancer Center Hospital

    RECRUITING

    Tokyo, Chuo-ku, 104-0045, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • National Cancer Center Hospital East

    RECRUITING

    Chiba, Kashiwa, 277-8577, Japan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Samsung Medical Center

    NOT_YET_RECRUITING

    Seoul, 06351, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Severance Hospital

    NOT_YET_RECRUITING

    Seoul, 03722, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shanghai East Hospital

    NOT_YET_RECRUITING

    Shanghai, 200120, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.